Healing / repair
ARA-290 (Cibinetide)
In clinical trialsCibinetide · Innate-repair-receptor agonist
Non-erythropoietic EPO-derived peptide for nerve/tissue repair.
What it is
An 11-amino-acid peptide derived from erythropoietin that keeps EPO's tissue-protective effects without raising red blood cells.
How it works
Activates the innate repair receptor to reduce inflammation and promote tissue and nerve repair.
Studied for
Neuropathic pain, sarcoidosis small-fiber neuropathy, diabetic effects (trials).
Regulatory status
Investigational; not FDA-approved.
Safety
Generally well tolerated in trials; long-term data limited.
Educational information only — not medical advice, and not a recommendation to use any compound. Many peptides here are not approved for human use; legal status and evidence quality vary and are noted above. This page contains no dosing information. Consult a qualified clinician before making any health decision.